カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のヒト用ワクチン接種市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Human Vaccination Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19401）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19401
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：110
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のヒト用ワクチン接種市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ヒト用ワクチン接種市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のヒト用ワクチン接種の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ヒト用ワクチン接種市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・不活化ワクチン、弱毒生ワクチン、mRNAワクチン、コンジュゲートワクチン、その他

用途別セグメントは次のように区分されます。
・政府機関、民間、その他

世界のヒト用ワクチン接種市場の主要な市場プレーヤーは以下のとおりです。
・GSK、Merck、Sanofi、Sinovac、Zhejiang Pukang、Changchun Institute of Biological、KM Biologics、IMBCAMS、Convac、NCPC、Bio Kangtai、Dynavax、Hissen、KM Biologics、LG Life Sciences、Serum Institute、Pfizer

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ヒト用ワクチン接種製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なヒト用ワクチン接種メーカーの企業概要、2019年～2022年までのヒト用ワクチン接種の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なヒト用ワクチン接種メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ヒト用ワクチン接種の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのヒト用ワクチン接種の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのヒト用ワクチン接種市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびヒト用ワクチン接種の産業チェーンを掲載しています。
・第13、14、15章では、ヒト用ワクチン接種の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ヒト用ワクチン接種の概要
- 種類別分析（2017年vs2021年vs2028年）：不活化ワクチン、弱毒生ワクチン、mRNAワクチン、コンジュゲートワクチン、その他
- 用途別分析（2017年vs2021年vs2028年）：政府機関、民間、その他
- 世界のヒト用ワクチン接種市場規模・予測
- 世界のヒト用ワクチン接種生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- GSK、Merck、Sanofi、Sinovac、Zhejiang Pukang、Changchun Institute of Biological、KM Biologics、IMBCAMS、Convac、NCPC、Bio Kangtai、Dynavax、Hissen、KM Biologics、LG Life Sciences、Serum Institute、Pfizer
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：不活化ワクチン、弱毒生ワクチン、mRNAワクチン、コンジュゲートワクチン、その他
・用途別分析2017年-2028年：政府機関、民間、その他
・ヒト用ワクチン接種の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ヒト用ワクチン接種のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ヒト用ワクチン接種のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ヒト用ワクチン接種の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ヒト用ワクチン接種の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Human Vaccination market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Vaccination market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Government Institution accounting for % of the Human Vaccination global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Inactivated Vaccine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Human Vaccination include GSK, Merck, Sanofi, Sinovac, and Zhejiang Pukang, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Vaccination market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Inactivated Vaccine
Live-attenuated Vaccine
mRNA Vaccine
Conjugate Vaccine
Other
Market segment by Application can be divided into
Government Institution
Private Sector
Other
The key market players for global Human Vaccination market are listed below:
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
NCPC
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Pfizer
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Vaccination product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Vaccination, with price, sales, revenue and global market share of Human Vaccination from 2019 to 2022.
Chapter 3, the Human Vaccination competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Vaccination breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Vaccination market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Vaccination.
Chapter 13, 14, and 15, to describe Human Vaccination sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Human Vaccination Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Vaccination Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Inactivated Vaccine
1.2.3 Live-attenuated Vaccine
1.2.4 mRNA Vaccine
1.2.5 Conjugate Vaccine
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Vaccination Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Global Human Vaccination Market Size & Forecast
1.4.1 Global Human Vaccination Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Vaccination Sales in Volume (2017-2028)
1.4.3 Global Human Vaccination Price (2017-2028)
1.5 Global Human Vaccination Production Capacity Analysis
1.5.1 Global Human Vaccination Total Production Capacity (2017-2028)
1.5.2 Global Human Vaccination Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Vaccination Market Drivers
1.6.2 Human Vaccination Market Restraints
1.6.3 Human Vaccination Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Human Vaccination Product and Services
2.1.4 GSK Human Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Human Vaccination Product and Services
2.2.4 Merck Human Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Human Vaccination Product and Services
2.3.4 Sanofi Human Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sinovac
2.4.1 Sinovac Details
2.4.2 Sinovac Major Business
2.4.3 Sinovac Human Vaccination Product and Services
2.4.4 Sinovac Human Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Zhejiang Pukang
2.5.1 Zhejiang Pukang Details
2.5.2 Zhejiang Pukang Major Business
2.5.3 Zhejiang Pukang Human Vaccination Product and Services
2.5.4 Zhejiang Pukang Human Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Changchun Institute of Biological
2.6.1 Changchun Institute of Biological Details
2.6.2 Changchun Institute of Biological Major Business
2.6.3 Changchun Institute of Biological Human Vaccination Product and Services
2.6.4 Changchun Institute of Biological Human Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 KM Biologics
2.7.1 KM Biologics Details
2.7.2 KM Biologics Major Business
2.7.3 KM Biologics Human Vaccination Product and Services
2.7.4 KM Biologics Human Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 IMBCAMS
2.8.1 IMBCAMS Details
2.8.2 IMBCAMS Major Business
2.8.3 IMBCAMS Human Vaccination Product and Services
2.8.4 IMBCAMS Human Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Convac
2.9.1 Convac Details
2.9.2 Convac Major Business
2.9.3 Convac Human Vaccination Product and Services
2.9.4 Convac Human Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 NCPC
2.10.1 NCPC Details
2.10.2 NCPC Major Business
2.10.3 NCPC Human Vaccination Product and Services
2.10.4 NCPC Human Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Bio Kangtai
2.11.1 Bio Kangtai Details
2.11.2 Bio Kangtai Major Business
2.11.3 Bio Kangtai Human Vaccination Product and Services
2.11.4 Bio Kangtai Human Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Dynavax
2.12.1 Dynavax Details
2.12.2 Dynavax Major Business
2.12.3 Dynavax Human Vaccination Product and Services
2.12.4 Dynavax Human Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Hissen
2.13.1 Hissen Details
2.13.2 Hissen Major Business
2.13.3 Hissen Human Vaccination Product and Services
2.13.4 Hissen Human Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 KM Biologics
2.14.1 KM Biologics Details
2.14.2 KM Biologics Major Business
2.14.3 KM Biologics Human Vaccination Product and Services
2.14.4 KM Biologics Human Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 LG Life Sciences
2.15.1 LG Life Sciences Details
2.15.2 LG Life Sciences Major Business
2.15.3 LG Life Sciences Human Vaccination Product and Services
2.15.4 LG Life Sciences Human Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Serum Institute
2.16.1 Serum Institute Details
2.16.2 Serum Institute Major Business
2.16.3 Serum Institute Human Vaccination Product and Services
2.16.4 Serum Institute Human Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Pfizer
2.17.1 Pfizer Details
2.17.2 Pfizer Major Business
2.17.3 Pfizer Human Vaccination Product and Services
2.17.4 Pfizer Human Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Human Vaccination Breakdown Data by Manufacturer
3.1 Global Human Vaccination Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Vaccination Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Vaccination
3.4 Market Concentration Rate
3.4.1 Top 3 Human Vaccination Manufacturer Market Share in 2021
3.4.2 Top 6 Human Vaccination Manufacturer Market Share in 2021
3.5 Global Human Vaccination Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Vaccination Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Vaccination Market Size by Region
4.1.1 Global Human Vaccination Sales in Volume by Region (2017-2028)
4.1.2 Global Human Vaccination Revenue by Region (2017-2028)
4.2 North America Human Vaccination Revenue (2017-2028)
4.3 Europe Human Vaccination Revenue (2017-2028)
4.4 Asia-Pacific Human Vaccination Revenue (2017-2028)
4.5 South America Human Vaccination Revenue (2017-2028)
4.6 Middle East and Africa Human Vaccination Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Human Vaccination Sales in Volume by Type (2017-2028)
5.2 Global Human Vaccination Revenue by Type (2017-2028)
5.3 Global Human Vaccination Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Human Vaccination Sales in Volume by Application (2017-2028)
6.2 Global Human Vaccination Revenue by Application (2017-2028)
6.3 Global Human Vaccination Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Human Vaccination Sales by Type (2017-2028)
7.2 North America Human Vaccination Sales by Application (2017-2028)
7.3 North America Human Vaccination Market Size by Country
7.3.1 North America Human Vaccination Sales in Volume by Country (2017-2028)
7.3.2 North America Human Vaccination Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Vaccination Sales by Type (2017-2028)
8.2 Europe Human Vaccination Sales by Application (2017-2028)
8.3 Europe Human Vaccination Market Size by Country
8.3.1 Europe Human Vaccination Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Vaccination Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Human Vaccination Sales by Type (2017-2028)
9.2 Asia-Pacific Human Vaccination Sales by Application (2017-2028)
9.3 Asia-Pacific Human Vaccination Market Size by Region
9.3.1 Asia-Pacific Human Vaccination Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Vaccination Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Human Vaccination Sales by Type (2017-2028)
10.2 South America Human Vaccination Sales by Application (2017-2028)
10.3 South America Human Vaccination Market Size by Country
10.3.1 South America Human Vaccination Sales in Volume by Country (2017-2028)
10.3.2 South America Human Vaccination Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Vaccination Sales by Type (2017-2028)
11.2 Middle East & Africa Human Vaccination Sales by Application (2017-2028)
11.3 Middle East & Africa Human Vaccination Market Size by Country
11.3.1 Middle East & Africa Human Vaccination Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Vaccination Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Human Vaccination and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Vaccination
12.3 Human Vaccination Production Process
12.4 Human Vaccination Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Vaccination Typical Distributors
13.3 Human Vaccination Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Human Vaccination Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Human Vaccination Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Human Vaccination Product and Services
Table 6. GSK Human Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Human Vaccination Product and Services
Table 10. Merck Human Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Human Vaccination Product and Services
Table 14. Sanofi Human Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sinovac Basic Information, Manufacturing Base and Competitors
Table 16. Sinovac Major Business
Table 17. Sinovac Human Vaccination Product and Services
Table 18. Sinovac Human Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Zhejiang Pukang Basic Information, Manufacturing Base and Competitors
Table 20. Zhejiang Pukang Major Business
Table 21. Zhejiang Pukang Human Vaccination Product and Services
Table 22. Zhejiang Pukang Human Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 24. Changchun Institute of Biological Major Business
Table 25. Changchun Institute of Biological Human Vaccination Product and Services
Table 26. Changchun Institute of Biological Human Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 28. KM Biologics Major Business
Table 29. KM Biologics Human Vaccination Product and Services
Table 30. KM Biologics Human Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. IMBCAMS Basic Information, Manufacturing Base and Competitors
Table 32. IMBCAMS Major Business
Table 33. IMBCAMS Human Vaccination Product and Services
Table 34. IMBCAMS Human Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Convac Basic Information, Manufacturing Base and Competitors
Table 36. Convac Major Business
Table 37. Convac Human Vaccination Product and Services
Table 38. Convac Human Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. NCPC Basic Information, Manufacturing Base and Competitors
Table 40. NCPC Major Business
Table 41. NCPC Human Vaccination Product and Services
Table 42. NCPC Human Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Bio Kangtai Basic Information, Manufacturing Base and Competitors
Table 44. Bio Kangtai Major Business
Table 45. Bio Kangtai Human Vaccination Product and Services
Table 46. Bio Kangtai Human Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Dynavax Basic Information, Manufacturing Base and Competitors
Table 48. Dynavax Major Business
Table 49. Dynavax Human Vaccination Product and Services
Table 50. Dynavax Human Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Hissen Basic Information, Manufacturing Base and Competitors
Table 52. Hissen Major Business
Table 53. Hissen Human Vaccination Product and Services
Table 54. Hissen Human Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 56. KM Biologics Major Business
Table 57. KM Biologics Human Vaccination Product and Services
Table 58. KM Biologics Human Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 60. LG Life Sciences Major Business
Table 61. LG Life Sciences Human Vaccination Product and Services
Table 62. LG Life Sciences Human Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 64. Serum Institute Major Business
Table 65. Serum Institute Human Vaccination Product and Services
Table 66. Serum Institute Human Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Major Business
Table 69. Pfizer Human Vaccination Product and Services
Table 70. Pfizer Human Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Global Human Vaccination Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Units)
Table 72. Global Human Vaccination Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 73. Market Position of Manufacturers in Human Vaccination, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 74. Global Human Vaccination Production Capacity by Company, (Units): 2020 VS 2021
Table 75. Head Office and Human Vaccination Production Site of Key Manufacturer
Table 76. Human Vaccination New Entrant and Capacity Expansion Plans
Table 77. Human Vaccination Mergers & Acquisitions in the Past Five Years
Table 78. Global Human Vaccination Sales by Region (2017-2022) & (Units)
Table 79. Global Human Vaccination Sales by Region (2023-2028) & (Units)
Table 80. Global Human Vaccination Revenue by Region (2017-2022) & (USD Million)
Table 81. Global Human Vaccination Revenue by Region (2023-2028) & (USD Million)
Table 82. Global Human Vaccination Sales by Type (2017-2022) & (Units)
Table 83. Global Human Vaccination Sales by Type (2023-2028) & (Units)
Table 84. Global Human Vaccination Revenue by Type (2017-2022) & (USD Million)
Table 85. Global Human Vaccination Revenue by Type (2023-2028) & (USD Million)
Table 86. Global Human Vaccination Price by Type (2017-2022) & (US$/Unit)
Table 87. Global Human Vaccination Price by Type (2023-2028) & (US$/Unit)
Table 88. Global Human Vaccination Sales by Application (2017-2022) & (Units)
Table 89. Global Human Vaccination Sales by Application (2023-2028) & (Units)
Table 90. Global Human Vaccination Revenue by Application (2017-2022) & (USD Million)
Table 91. Global Human Vaccination Revenue by Application (2023-2028) & (USD Million)
Table 92. Global Human Vaccination Price by Application (2017-2022) & (US$/Unit)
Table 93. Global Human Vaccination Price by Application (2023-2028) & (US$/Unit)
Table 94. North America Human Vaccination Sales by Country (2017-2022) & (Units)
Table 95. North America Human Vaccination Sales by Country (2023-2028) & (Units)
Table 96. North America Human Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 97. North America Human Vaccination Revenue by Country (2023-2028) & (USD Million)
Table 98. North America Human Vaccination Sales by Type (2017-2022) & (Units)
Table 99. North America Human Vaccination Sales by Type (2023-2028) & (Units)
Table 100. North America Human Vaccination Sales by Application (2017-2022) & (Units)
Table 101. North America Human Vaccination Sales by Application (2023-2028) & (Units)
Table 102. Europe Human Vaccination Sales by Country (2017-2022) & (Units)
Table 103. Europe Human Vaccination Sales by Country (2023-2028) & (Units)
Table 104. Europe Human Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 105. Europe Human Vaccination Revenue by Country (2023-2028) & (USD Million)
Table 106. Europe Human Vaccination Sales by Type (2017-2022) & (Units)
Table 107. Europe Human Vaccination Sales by Type (2023-2028) & (Units)
Table 108. Europe Human Vaccination Sales by Application (2017-2022) & (Units)
Table 109. Europe Human Vaccination Sales by Application (2023-2028) & (Units)
Table 110. Asia-Pacific Human Vaccination Sales by Region (2017-2022) & (Units)
Table 111. Asia-Pacific Human Vaccination Sales by Region (2023-2028) & (Units)
Table 112. Asia-Pacific Human Vaccination Revenue by Region (2017-2022) & (USD Million)
Table 113. Asia-Pacific Human Vaccination Revenue by Region (2023-2028) & (USD Million)
Table 114. Asia-Pacific Human Vaccination Sales by Type (2017-2022) & (Units)
Table 115. Asia-Pacific Human Vaccination Sales by Type (2023-2028) & (Units)
Table 116. Asia-Pacific Human Vaccination Sales by Application (2017-2022) & (Units)
Table 117. Asia-Pacific Human Vaccination Sales by Application (2023-2028) & (Units)
Table 118. South America Human Vaccination Sales by Country (2017-2022) & (Units)
Table 119. South America Human Vaccination Sales by Country (2023-2028) & (Units)
Table 120. South America Human Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 121. South America Human Vaccination Revenue by Country (2023-2028) & (USD Million)
Table 122. South America Human Vaccination Sales by Type (2017-2022) & (Units)
Table 123. South America Human Vaccination Sales by Type (2023-2028) & (Units)
Table 124. South America Human Vaccination Sales by Application (2017-2022) & (Units)
Table 125. South America Human Vaccination Sales by Application (2023-2028) & (Units)
Table 126. Middle East & Africa Human Vaccination Sales by Region (2017-2022) & (Units)
Table 127. Middle East & Africa Human Vaccination Sales by Region (2023-2028) & (Units)
Table 128. Middle East & Africa Human Vaccination Revenue by Region (2017-2022) & (USD Million)
Table 129. Middle East & Africa Human Vaccination Revenue by Region (2023-2028) & (USD Million)
Table 130. Middle East & Africa Human Vaccination Sales by Type (2017-2022) & (Units)
Table 131. Middle East & Africa Human Vaccination Sales by Type (2023-2028) & (Units)
Table 132. Middle East & Africa Human Vaccination Sales by Application (2017-2022) & (Units)
Table 133. Middle East & Africa Human Vaccination Sales by Application (2023-2028) & (Units)
Table 134. Human Vaccination Raw Material
Table 135. Key Manufacturers of Human Vaccination Raw Materials
Table 136. Direct Channel Pros & Cons
Table 137. Indirect Channel Pros & Cons
Table 138. Human Vaccination Typical Distributors
Table 139. Human Vaccination Typical Customers
List of Figures
Figure 1. Human Vaccination Picture
Figure 2. Global Human Vaccination Revenue Market Share by Type in 2021
Figure 3. Inactivated Vaccine
Figure 4. Live-attenuated Vaccine
Figure 5. mRNA Vaccine
Figure 6. Conjugate Vaccine
Figure 7. Other
Figure 8. Global Human Vaccination Revenue Market Share by Application in 2021
Figure 9. Government Institution
Figure 10. Private Sector
Figure 11. Other
Figure 12. Global Human Vaccination Revenue, (USD Million) & (Units): 2017 & 2021 & 2028
Figure 13. Global Human Vaccination Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Human Vaccination Sales (2017-2028) & (Units)
Figure 15. Global Human Vaccination Price (2017-2028) & (US$/Unit)
Figure 16. Global Human Vaccination Production Capacity (2017-2028) & (Units)
Figure 17. Global Human Vaccination Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Human Vaccination Market Drivers
Figure 19. Human Vaccination Market Restraints
Figure 20. Human Vaccination Market Trends
Figure 21. Global Human Vaccination Sales Market Share by Manufacturer in 2021
Figure 22. Global Human Vaccination Revenue Market Share by Manufacturer in 2021
Figure 23. Human Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Human Vaccination Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Human Vaccination Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Human Vaccination Sales Market Share by Region (2017-2028)
Figure 27. Global Human Vaccination Revenue Market Share by Region (2017-2028)
Figure 28. North America Human Vaccination Revenue (2017-2028) & (USD Million)
Figure 29. Europe Human Vaccination Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Human Vaccination Revenue (2017-2028) & (USD Million)
Figure 31. South America Human Vaccination Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Human Vaccination Revenue (2017-2028) & (USD Million)
Figure 33. Global Human Vaccination Sales Market Share by Type (2017-2028)
Figure 34. Global Human Vaccination Revenue Market Share by Type (2017-2028)
Figure 35. Global Human Vaccination Price by Type (2017-2028) & (US$/Unit)
Figure 36. Global Human Vaccination Sales Market Share by Application (2017-2028)
Figure 37. Global Human Vaccination Revenue Market Share by Application (2017-2028)
Figure 38. Global Human Vaccination Price by Application (2017-2028) & (US$/Unit)
Figure 39. North America Human Vaccination Sales Market Share by Type (2017-2028)
Figure 40. North America Human Vaccination Sales Market Share by Application (2017-2028)
Figure 41. North America Human Vaccination Sales Market Share by Country (2017-2028)
Figure 42. North America Human Vaccination Revenue Market Share by Country (2017-2028)
Figure 43. United States Human Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Human Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Human Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Human Vaccination Sales Market Share by Type (2017-2028)
Figure 47. Europe Human Vaccination Sales Market Share by Application (2017-2028)
Figure 48. Europe Human Vaccination Sales Market Share by Country (2017-2028)
Figure 49. Europe Human Vaccination Revenue Market Share by Country (2017-2028)
Figure 50. Germany Human Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Human Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Human Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Human Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Human Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Human Vaccination Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Human Vaccination Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Human Vaccination Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Human Vaccination Revenue Market Share by Region (2017-2028)
Figure 59. China Human Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Human Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Human Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Human Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Human Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Human Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Human Vaccination Sales Market Share by Type (2017-2028)
Figure 66. South America Human Vaccination Sales Market Share by Application (2017-2028)
Figure 67. South America Human Vaccination Sales Market Share by Country (2017-2028)
Figure 68. South America Human Vaccination Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Human Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Human Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Human Vaccination Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Human Vaccination Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Human Vaccination Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Human Vaccination Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Human Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Human Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Human Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Human Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Human Vaccination in 2021
Figure 80. Manufacturing Process Analysis of Human Vaccination
Figure 81. Human Vaccination Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ヒト用ワクチン接種のグローバル市場展望 2023年-2029年：不活化ワクチン、弱毒化生ワクチン、mRNAワクチン、結合型ワクチン、その他
  • 世界の人間用狂犬病予防接種市場2022年：市場規模予測（～2028年）
  • ヒト用狂犬病ワクチン接種のグローバル市場展望 2023年-2029年：ベロ細胞、BHK、ニワトリ胚細胞、ヒト二倍体細胞、その他
  • 世界の狂犬病予防接種市場2022年：市場規模予測（～2028年）
  • 世界の肺炎球菌ワクチン接種市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19401 )"世界のヒト用ワクチン接種市場2022年：市場規模予測（～2028年）" (英文：Global Human Vaccination Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。